Literature DB >> 8901368

Comparison of conditional quality of life terminology and visual analogue scale measurements.

S M Grunberg1, S Groshen, S Steingass, S Zaretsky, B Meyerowitz.   

Abstract

Two common formats for grading quality of life parameters are descriptive choices (mild, moderate, severe) and visual analogue scales. However the quantitative relationship between descriptive terminology and visual analogue scale scores has not been determined. A content neutral questionnaire was administered to 213 evaluable subjects who were asked to place the descriptors 'mildly', 'moderately', and 'severely' (presented in random order) on 100mm visual analogue scales. Visual analogue scales were presented without and then with hashmarks at 25mm, 50mm, and 75mm. Median visual analogue scale values for the descriptive terms differed significantly without hashmarks ('mildly' = 24mm', moderately' = 43mm, 'severely' = 84mm; p < 0.001) and also with hashmarks ('mildly' = 31mm, 'moderately' = 49mm, 'severely' = 85mm; p < 0.001). Comparison of interquartile range values (25th-75th percentile) revealed a distinct meaning for 'severely' (68-93mm) but marked overlap between 'mildly' (10-45mm) and 'moderately' (22-53mm). Errors of order (order other than 'mildly' < 'moderately' < 'severely') were made by 91 subjects. The discrepancy 'moderately' < 'mildly' accounted for most of these errors (72 subjects). Median values for 'mildly', 'moderately', and 'severely' are distinct and approximately linear on a visual analogue scale for large populations. However there is significant confusion between the terms 'mildly' and 'moderately' for individual subjects. Visual analogue scales can reveal finer quantitative differences than descriptive terms but require a significant time commitment for instruction and administration. Descriptive terms on a word-graphic scale or descriptive terms with numerical values to reenforce order of severity (0 = absent, 1 = 'mildly', 2 = 'moderately', 3 = 'severely') may be reasonable alternatives.

Mesh:

Year:  1996        PMID: 8901368     DOI: 10.1007/bf00435970

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  15 in total

1.  The word-graphic rating scale as a measure of children's and adolescents' pain intensity.

Authors:  M D Tesler; M C Savedra; W L Holzemer; D J Wilkie; J A Ward; S M Paul
Journal:  Res Nurs Health       Date:  1991-10       Impact factor: 2.228

2.  A comparison of seven-point and visual analogue scales. Data from a randomized trial.

Authors:  R Jaeschke; J Singer; G H Guyatt
Journal:  Control Clin Trials       Date:  1990-02

Review 3.  A clinician's guide to cost-effectiveness analysis.

Authors:  A S Detsky; I G Naglie
Journal:  Ann Intern Med       Date:  1990-07-15       Impact factor: 25.391

4.  Measuring quality of life: risks and benefits.

Authors:  H Schipper; M Levitt
Journal:  Cancer Treat Rep       Date:  1985-10

Review 5.  Quality of life in cancer: definition, purpose, and method of measurement.

Authors:  D F Cella; D S Tulsky
Journal:  Cancer Invest       Date:  1993       Impact factor: 2.176

6.  Validity and reliability of a scale to assess fatigue.

Authors:  K A Lee; G Hicks; G Nino-Murcia
Journal:  Psychiatry Res       Date:  1991-03       Impact factor: 3.222

7.  Acceptability of visual analogue scales in the clinical setting: a comparison with verbal rating scales in postoperative pain.

Authors:  J E Baños; F Bosch; M Cañellas; A Bassols; F Ortega; J Bigorra
Journal:  Methods Find Exp Clin Pharmacol       Date:  1989-02

8.  Quantitative pain assessment for routine care of rheumatoid arthritis patients, using a pain scale based on activities of daily living and a visual analog pain scale.

Authors:  L F Callahan; R H Brooks; J A Summey; T Pincus
Journal:  Arthritis Rheum       Date:  1987-06

9.  A Visual Analogue Scale technique to measure global vigor and affect.

Authors:  T H Monk
Journal:  Psychiatry Res       Date:  1989-01       Impact factor: 3.222

10.  Quality of life assessment in individuals with lung cancer: testing the Lung Cancer Symptom Scale (LCSS).

Authors:  P J Hollen; R J Gralla; M G Kris; L M Potanovich
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

View more
  19 in total

1.  What is the quality of life in the oldest old?

Authors:  Maria I Lapid; Teresa A Rummans; Bradley F Boeve; Joan K McCormick; V Shane Pankratz; Ruth H Cha; Glenn E Smith; Robert J Ivnik; Eric G Tangalos; Ronald C Petersen
Journal:  Int Psychogeriatr       Date:  2011-02-01       Impact factor: 3.878

2.  A survey of U.S. physicians and their partners regarding the impact of work-home conflict.

Authors:  Liselotte N Dyrbye; Wayne Sotile; Sonja Boone; Colin P West; Litjen Tan; Daniel Satele; Jeff Sloan; Mick Oreskovich; Tait Shanafelt
Journal:  J Gen Intern Med       Date:  2013-09-17       Impact factor: 5.128

3.  Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial.

Authors:  Amanda R Moraska; Amit Sood; Shaker R Dakhil; Jeff A Sloan; Debra Barton; Pamela J Atherton; Jason J Suh; Patricia C Griffin; David B Johnson; Aneela Ali; Peter T Silberstein; Steven F Duane; Charles L Loprinzi
Journal:  J Clin Oncol       Date:  2010-07-12       Impact factor: 44.544

4.  Effect of cigarette smoking on quality of life in small cell lung cancer patients.

Authors:  Jun Chen; Yingwei Qi; Jason A Wampfler; Aminah Jatoi; Yolanda I Garces; Allan J Busta; Sumithra J Mandrekar; Ping Yang
Journal:  Eur J Cancer       Date:  2012-01-12       Impact factor: 9.162

5.  QOL and Survival Comparisons by Race in Oncology Clinical Trials.

Authors:  A D Tan; P J Novotny; J S Kaur; J C Buckner; R B Mowat; E Paskett; J A Sloan
Journal:  J Cancer Clin Oncol       Date:  2016-11-16

6.  N0539 phase II trial of fulvestrant and bevacizumab in patients with metastatic breast cancer previously treated with an aromatase inhibitor: a North Central Cancer Treatment Group (now Alliance) trial.

Authors:  W W Tan; A C Dueck; P Flynn; P Steen; D Anderson; K Rowland; D Northfelt; E A Perez
Journal:  Ann Oncol       Date:  2013-06-24       Impact factor: 32.976

7.  Overall survival and self-reported fatigue in patients with esophageal cancer.

Authors:  M C Stauder; Y Romero; B Kabat; P J Atherton; D Geno; C Deschamps; A Jatoi; J A Sloan; M Botros; K W Jung; A S Arora; R C Miller
Journal:  Support Care Cancer       Date:  2012-07-29       Impact factor: 3.603

8.  Colorectal tumour microsatellite instability test results: perspectives from patients.

Authors:  Noralane M Lindor; Jeff Sloan; Richard Goldberg; Deborah Bowen; Sandra Nigon; Amber Roche; Gloria Petersen; Stephen N Thibodeau; Laurence Burgart; Olga Leontovich; Bruce W Morlan
Journal:  Hered Cancer Clin Pract       Date:  2004-05-15       Impact factor: 2.857

9.  Marital status and quality of life in patients with esophageal cancer or Barrett's esophagus: the mayo clinic esophageal adenocarcinoma and Barrett's esophagus registry study.

Authors:  Robert C Miller; Pamela J Atherton; Brian F Kabat; Mary B Fredericksen; Debra M Geno; Claude Deschamps; Aminah Jatoi; Jeff A Sloan; Yvonne Romero
Journal:  Dig Dis Sci       Date:  2010-01-22       Impact factor: 3.199

10.  ApoE and quality of life in nonagenarians.

Authors:  Ajay K Parsaik; Maria I Lapid; Teresa A Rummans; Ruth H Cha; Bradley F Boeve; Vernon S Pankratz; Eric G Tangalos; Ronald C Petersen
Journal:  J Am Med Dir Assoc       Date:  2012-08-03       Impact factor: 4.669

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.